Smoking cessation and risk of myocardial reinfarction in coronary patients: A nested case-control study;Abandono del tabaco y riesgo de nuevo infarto en pacientes coronarios: Estudio de casos y controles anidado

Revista Espanola de Cardiologia

Volumn 56, Issue 5, 2003, Pages 445-451

  Serrano Martinez, Manuel ^a,b   Madoz, Edurne ^b   Ezpeleta, Isabel ^b   San Julián, Beatriz ^b   Amézqueta, Carlos ^b   Pérez Marco, José Antonio ^b   de Irala, Jokin ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

Author keywords

Coronary disease; Lifestyle; Myocardial infarction; Prevention; Smoking

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FAMILY HISTORY; HEART INFARCTION PREVENTION; HEART REINFARCTION; HOSPITAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MORTALITY; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING CESSATION; SURVIVAL TIME; TIME;

EID: 0038729508     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13047008     Document Type: Article

References (29)

1. Bairey Merz CN, Rozanski A, Forrester JS. The secondary prevention of coronary artery disease. Am J Med 1997;102:572-81.
2. McAlister FA, Lawson FME, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62.
3. Winniford MD, Jansen DE, Reynolds GA, Apprill P, Black WH, Hillis LD. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. Am J Cardiol 1987;59:203-7.
4. Davis JW, Hartman CR, Lewis HD Jr, Shelton L, Eigenberg DA, Hassanein KM, et al. Cigarette smoking-induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985;105:479-83.
5. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987;113:1006-10.
6. Taylor AE, Johnson DC, Kazemi H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation 1992;86:699-702.
7. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
8. DeBusk RF, Miller NH, Superko HR, Dennis CA, Thomas RJ, Lew HT, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-9.
9. Di Tullio M, Granata D, Taioli E, Broccolino M, Recalcati F, Zaini G, et al. Early predictors of smoking cessation after myocardial infarction. Clin Cardiol 1991;14:809-12.
10. Rodríguez Artalejo F, Banegas Banegas JR. ¿Era necesario demostrar también en España que la colesterolemia y el tabaco son factores de riesgo cardiovascular? Rev Esp Cardiol 2001;54:1141-2.
11. Ordovás JM. Colesterol y tabaco: clásicos que perduran en el tiempo. Rev Esp Cardiol 2001;54:1143-5.
12. WHO MONICA Project. MONICA manual. Geneva: WHO, 1990; part IV(a): p. 11-32.
13. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001;12:892-902.
14. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, et al, for the SHIP Collaborative Group. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). BMJ 1999;318:706-11.
15. Brady AJ, Oliver MA, Pittard JB. Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care. BMJ 2001;1322:463.
16. Van Berkel TF, Boersma H, De Baquer D, Deckers JW, Wood D. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. Eur Heart J 1999;20:1630-7.
17. Naylor M, Brooten D, Jones R, Lavizzo-Mourey R, Mezey M, Pauly M. Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial. Ann Intern Med 1994;120:999-1006.
18. Prevention of coronary heart disease in clinical practice. Recommendation of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.
19. Greenwood DC, Muir KR, Packham CJ, Madeley RJ. Stress, social support, and stopping smoking after myocardial infarction in England. J Epidemiol Community Health 1995;49:583-7.
20. Johansson S, Bergstrand R, Pennert K, Ulvenstam G, Vedin A, Wedel H, et al. Cessation of smoking after myocardial infarction in women. Effects on mortality and reinfarctions. Am J Epidemiol 1985;121:823-31.
21. Aberg A, Bergstrand R, Johansson S, Ulvenstam G, Vedin A, Wedel H, et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J 1983;49:416-22.
22. Mulcahy R, Hickey N, Graham IM, MacAirt J. Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J 1977;93:556-9.
23. Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J 1993;14:831-5.
24. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002; 137:494-500.
25. Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001;35:589-617.
26. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
27. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988;319:1365-9.
28. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up. Ann Intern Med 1994; 120:287-93.
29. Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martínez-González MA. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care 2000;23:1455-60.